Parakeet Health raises a $10M Series A led by Canvas Ventures to expand AI patient outreach beyond dermatology.
Sanofi pays Regeneron $1B upfront, with up to $7B more, to co-develop four long-acting immunology antibodies as Dupixent's patent cliff nears.
The Centers for Medicare and Medicaid Services finalized a demonstration program aimed at lowering the prices of ...
Bristol Myers discloses a fatal liver injury in its Phase 3 program for pulmonary fibrosis drug admilparant ahead of a Q4 ...
The American Biotech Innovation Alliance pressed Congress this week on US-China biotech competition, citing FDA capacity ...
Varda Space Industries raises a $251M Series D, valuing it at $1.6B, to advance space-based drug manufacturing using low ...
Forget Wegovy and Zepbound. Never mind CagriSema, and even retatrutide. The latest big name in obesity is eloraTZP. Data ...
NCI director Ned Sharpless as MD and Andrew Witty as chairman, while raising a $100M second opportunities fund.
Merck's tulisokibart showed mid-stage success in hidradenitis suppurativa, with 72% high-dose patients seeing 50%+ abscess ...
Zealand and Roche's petrelintide peaks at 10.7% weight loss at its middle dose in Ph2, trailing Lilly's eloralintide at 20.1% ...
Former House majority leader Eric Cantor has been chosen as PhRMA’s next CEO, according to two sources familiar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results